GMABGenmab A/S
$43.78+34% 1Y
$43.78
$23.8552 weeks$43.78
Latest close: a new 52-week highOct 23, 2026what changed →
Is the price fair?
What GMAB's price assumes
Genmab A/S has no trailing P/E on file, so the price is measured against sales instead: 0.04× revenue.
0.04
Price / sales · no trailing P/E on file: measured against sales instead
- Price / book
- 0.04
Price / book · as of 2024-H2
Details›
- Price / bookas of 2024-H2
- 0.04
- Market capitalisation517.8 million shares, counted Dec 31, 2025
- $22.7B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.